Skip to content

Hikma Pharmaceuticals

UK-headquartered pharmaceutical company

HIK London SE ISIN GB00B0LCW083 LEI 549300BNS685UXH4JI75

Follow Hikma Pharmaceuticals Weekly email: filings, results, news

News

3 stories filed under Hikma Pharmaceuticals, grouped into ongoing threads

Story

Thread · 2 stories · active today

Hikma (LSE:HIK) Opens Its R&D Playbook This Week: Can A Bigger Pipeline Push Reshape The Story?

Markets 19 h ago

Is Hikma (LSE:HIK) Reshaping Its Growth Story With A Semaglutide Launch And R&D Spotlight This Week?

Policy 1 d ago

More coverage

Hikma Pharmaceuticals names Rebecca Hall as CFO

Markets 1 d ago

Profile

Headquarters: London, United Kingdom
Legal name: HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY
Founded: 1978
CEO: Said Darwazah
Sector: Healthcare
Industry: pharmaceutical industry
LEI: 549300BNS685UXH4JI75
Website: hikma.com

Peers

Where this page comes from

Profile · GLEIF, Wikidata

News · 3 stories clustered from the RSS aggregator